Gilead Sciences' market capitalization had increased by 26.3 billion U.S. dollars up to May 27, 2020. Gilead Sciences shot to the public spotlight due to trials of its drug remdesivir which is seen as a possible treatment for COVID-19.
Pharma companies involved in COVID-19 R&D with largest market capitalization change until May 27, 2020
(in billion U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Evaluate. (May 28, 2020). Pharma companies involved in COVID-19 R&D with largest market capitalization change until May 27, 2020 (in billion U.S. dollars) [Graph]. In Statista. Retrieved September 20, 2024, from https://www.statista.com/statistics/1110159/key-covid-19-market-movers-by-market-cap-change/
Evaluate. "Pharma companies involved in COVID-19 R&D with largest market capitalization change until May 27, 2020 (in billion U.S. dollars)." Chart. May 28, 2020. Statista. Accessed September 20, 2024. https://www.statista.com/statistics/1110159/key-covid-19-market-movers-by-market-cap-change/
Evaluate. (2020). Pharma companies involved in COVID-19 R&D with largest market capitalization change until May 27, 2020 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: September 20, 2024. https://www.statista.com/statistics/1110159/key-covid-19-market-movers-by-market-cap-change/
Evaluate. "Pharma Companies Involved in Covid-19 R&d with Largest Market Capitalization Change until May 27, 2020 (in Billion U.S. Dollars)." Statista, Statista Inc., 28 May 2020, https://www.statista.com/statistics/1110159/key-covid-19-market-movers-by-market-cap-change/
Evaluate, Pharma companies involved in COVID-19 R&D with largest market capitalization change until May 27, 2020 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/1110159/key-covid-19-market-movers-by-market-cap-change/ (last visited September 20, 2024)
Pharma companies involved in COVID-19 R&D with largest market capitalization change until May 27, 2020 (in billion U.S. dollars) [Graph], Evaluate, May 28, 2020. [Online]. Available: https://www.statista.com/statistics/1110159/key-covid-19-market-movers-by-market-cap-change/